From: New insight into circRNAs: characterization, strategies, and biomedical applications
Cancer | Name | Up/down | Characteristic | Refs. |
---|---|---|---|---|
Hematologic malignancies | ||||
AML | Circ_0009910 | Up | Silencing Circ_0009910 can significantly inhibit proliferation, sphere formation and promote apoptosis | [226] |
AML | Circ-SFMBT2 | Up | Silencing Circ-SFMBT2 can inhibit the proliferation, migration, invasion and glycolysis of AML cells and induce apoptosis | [227] |
AML | circ_0040823 | Down | Overexpression of circ_0040823 inhibited the proliferation of AML cells and induced apoptosis and cell cycle arrest | [184] |
AML | hsa_circ_0079480 | Up | Associated with overall survival and relapse-free survival of AML | [228] |
AML | circ_0004277 | Down | Overexpression of circ 0004277 inhibited the migration and invasion of AML cells | [183] |
ALL | Circ_0000745 | Up | Knockdown of Circ_0000745 inhibits cell cycle progression and glycolysis, and induces apoptosis and iron death | [229] |
ALL | circ_0008012 | Up | related to proliferation and apoptosis of ALL cells | [230] |
CLL | circ-CBFB | Up | Knockdown of circ-CBFB inhibited the proliferation of CLL cells, stopped the cell cycle and induced apoptosis | [231] |
CLL | hsa_circ_0132266 | Down | Inhibition of CLL cell apoptosis and impaired proliferation | [232] |
CLL | Hsa_circ_0064574 | Up | highly expressed in the plasma of CLL patients | [233] |
CLL | circZNF91 | Up | Silencing circZNF91 can inhibit CLL cell proliferation, induce apoptosis and block cell cycle | [234] |
CML | Hsa_circ_0058493 | Up | Increase the resistance of CML cells to imatinib | [235] |
CML | circ_0080145 | Up | Increase the resistance of CML cells to imatinib | [236] |
CML | circ_0051886 | Up | Increase the resistance of CML cells to imatinib | [236] |
MM | Circ_0000190 | Down | Inhibiting the viability, proliferation and inducing apoptosis | [237] |
MM | hsa_circ_0007841 | Up | Associated with drug resistance and chromosome aberration | [38] |
MM | circITCH | Down | Related to the resistance of MM cells to bortezomib (BTZ) | [238] |
Digestive system malignancy | Â | |||
CRC | Hsa_circ_0082182 | Up | Associated with tumor proliferation and lymph node metastasis | [239] |
CRC | Hsa_circ_0000370 | Up | Associated with tumor proliferation and lymph node metastasis | [239] |
CRC | hsa_circ_0004585 | Up | Positively correlated with tumor size | [240] |
CRC | hsa_circ_0000567 | Down | Negatively correlated with tumor size, lymph node metastasis, remote metastasis, and TNM staging | [241] |
CRC | hsa_circ_0004771 | Up | Upregulated in tumor cell-derived plasma exosomes | [242] |
HCC | circIPO11 | Up | Drives self-renewal of liver cancer | [123] |
HCC | hsa_circ_0000798 | Up | High expression in liver cancer tissues was negatively correlated with the overall survival cycle of patients | [243] |
HCC | hsa_circ_0027089 | Up | Distinguishing cirrhosis | [244] |
HCC | hsa_circ_0058124 | Up | Associated with invasive characteristics, also regulates the resistance of liver cancer cells to sorafenib | [245] |
HCC | hsa_circSMARCA5 | Down | Related to proliferation, invasion and metastasis | [246] |
HCC | hsa_circ_0068669 | Down | Related to tumor microvascular invasion and TNM staging | [247] |
HCC | hsa_circ_0028502 | Down | associated with lymph node metastasis and TNM stage | [248] |
HCC | hsa_circ_0076251 | Down | Associated with Barcelona Clinic Liver Cancer (BCLC) stage | [248] |
HCC | circUBAP2 | Up | Negatively correlated with aggressive clinical characteristics | [249] |
HCC | circRNA-YBX1 | Down | Mediate phase separation suppresses the metastasis | Â |
GC | circNRIP1 | Â | Inhibit the growth of gastric cancer | [179] |
GC | hsa_circ_0003159 | Down | Negative correlation between tumor metastasis and TNM stage | [250] |
GC | hsa_circ_0000096 | Down | Affects the growth and migration of GC cells | [251] |
GC | hsa_circ_002059 | Down | Associated with distal metastasis of tumor cells and TNM staging | [252] |
GC | hsa_circ_0000190 | Down | Related to tumor diameter, lymphoid metastasis, distal metastasis and TNM stage | [253] |
GC | hsa_circ_0000181 | Down | Associated with tumor diameter, lymphoid metastasis | [254] |
GC | hsa_circ_0000467 | Up | Closely related to TNM staging | [255] |
GC | hsa_circ_0001895 | Down | Down-regulated in GC tissue and precancerous stage of GC | [256] |
GC | hsa_circ_0017728 | Up | Associated with short overall survival, poor pathological differentiation, higher TNM stage and lymph node metastasis | [257] |
GC | circPDIA4 | Up | Accelerate the invasion of cancer cells in vitro, promote the progression of GC and indicate poor prognosis | [258] |
BC | Hsa_circ_0001136 | Up | Associated with tumor grade, tumor stage, lymph node invasion and distal metastasis | [259] |
BC | hsa_circ_0137439 | Up | Related to tumor grade, tumor stage, lymph node invasion, also can distinguish between MIBC and NMIBC | [260] |
BC | hsa_circ_0001361 | Up | Promoted the invasion and metastasis of bladder cancer cells and was positively correlated with pathological grade | [261] |
BC | circSLC8A1 | Down | Overexpression inhibits the migration, invasion and proliferation of tumor cells | [262] |
PC | circANAPC7 | Down | Inhibits Tumor Growth and Muscle Wasting | [180] |
PC | Circ-MBOAT2 | Up | Regulates cell proliferation, migration, invasion and glutamine catabolism | [181] |
PC | circRNA IARS | Up | Positively correlated with hepatic metastasis, vascular infiltration and TNM stage of pancreatic ductal adenocarcinoma (PDAC), and negatively correlated with postoperative survival time | [263] |
PC | hsa_circRNA_001859 | Down | Inhibit the proliferation, invasion and EMT of pancreatic cancer | [264] |
OSCC | Hsa_circ_0001971 | Up | Related to TNM stage of tumor | [265] |
OSCC | Hsa_circ_0001874 | Up | Related to tumor grade and TNM stage | [265] |
OSCC | Hsa_circ_0003829 | Down | Negatively correlated with lymph node metastasis and TNM stage | [266] |
OSCC | Circ_0109291 | Up | Silencing circ_0109291 can improve tumor sensitivity to DDP | [267] |
ESCC | Hsa_circ_0003823 | Up | Promotes the Tumor Progression, Metastasis and Apatinib Resistance | [167] |
ESCC | circPUM1 | Up | Regulates oxidative phosphorylation | [168] |
ESCC | circCYP24A1 | Up | Facilitates esophageal squamous cell carcinoma progression | [169] |
ESCC | circCNOT6L | Up | Regulates cell development | [170] |
ESCC | circGSK3β | Up | Promotes metastasis | [171] |
EC | circ-VIM | Up | Silencing circ-VIM in vitro can inhibit immune escape and multiple carcinogenic activities of EC cells, as well as inhibit internal xenograft growth and lung metastasis | [182] |
Lung cancer | ||||
LC | Hsa_circ_0001715 | Up | Related to TNM stage and distant metastasis of lung adenocarcinoma, and inversely proportional to overall survival | [268] |
LC | Hsa_circ_0005962 | Up | Promote the proliferation of lung adenocarcinoma cells (LUAD) | [269] |
LC | Hsa_circ_0086414 | Down | Plasma hsa_circ_0086414 was related to EGFR mutations | [269] |
LC | Hsa_circ_002178 | Up | Promotes the expression of PDL1/PD1 in lung adenocarcinoma cells and is also present in exosomes | [270] |
LC | Hsa_circ_0037515 | Down | Significantly down-regulated in non-small cell lung cancer (NSCLC) | [271] |
LC | Hsa_circ_0037516 | Down | significantly down-regulated in non-small cell lung cancer | [271] |
LC | hsa_circ_0001073 | Down | Indicates the lung adenocarcinoma (LUAD) subtype in non-small cell lung cancer | [165] |
LC | hsa_circ_0001495 | Up | Indicates the squamous cell carcinoma (LUSC) subtype in non-small cell lung cancer | [165] |
Others | ||||
RC | circHIAT1 | Down | Overexpression inhibits the malignant progression of clear cell renal cell carcinoma | [272] |
RC | hsa_circ_001895 | Up | Promotes ccRCC cell proliferation, invasion and migration and is associated with poor prognosis | [273] |
GM | circRNA-104718 | Up | Indicates a poor prognosis and promotes invasion and migration of tumor cells | [274] |
GM | circ-GLIS3 | Up | Related to the resistance of temozolomide (TMZ) and promotes the proliferation, invasion and migration of glioma cells | [275] |
GM | Circ_0047688 | Up | Promote malignant behavior of glioma cells | [276] |
GM | Circ_0001982 | Up | Promote the proliferation, migration and invasion of glioma cells | [277] |
GM | has-circ-0072688 | Up | Promote the proliferation of glioblastoma and inhibit apoptosis | [278] |
GM | hsa_circ_0030018 | Up | Promote proliferation and inhibit apoptosis of glioma cells | [279] |
Breast cancer | hsa_circ_0008673 | Up | Related to tumor size and distal metastasis | [280] |
Breast cancer | Circ-LARP4 | Down | High expression indicates good prognosis and is negatively correlated with tumor size | [175] |
Breast cancer | circRNA-CREIT | Down | Increases drug resistance in triple negative breast cancer (TNBC) and is associated with poor prognosis | [40] |
OC | circBNC2 | Down | associated with advanced cancer and lymph node metastasis in epithelial ovarian cancer (EOC) | [281] |
TC | Hsa_circ_0137287 | Down | related to tumor size, lymph node metastasis and TNM stage | [282] |
CC | Circ_0000745 | Up | Knockdown Circ_0000745 inhibited proliferation, migration, invasion and glycolysis of cervical cancer cells | [283] |